China Universal Asset Management Company’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$437K Buy
2025
Q1
$551K Sell
2024
Q4
$842K Buy
2024
Q3
$675K Buy
2024
Q2
$547K Sell
2024
Q1
$1.36M Buy
2023
Q4
$821K Buy
2023
Q3
$115K Buy
2023
Q2
$213K Sell
2023
Q1
$156K Buy
2022
Q4
$58.1K Buy
2022
Q3
$70K Buy